SBCWW:NSD-SBC Medical Group Holdings Incorporated (USD)

COMMON STOCK | Consulting Services |

Last Closing

USD 0.2444

Change

-0.02 (-6.00)%

Market Cap

N/A

Volume

204.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-24 )

Largest Industry Peers for Consulting Services

Symbol Name Price(Change) Market Cap
VRSK Verisk Analytics Inc

N/A

USD 40.01B
ICFI ICF International Inc

N/A

USD 2.38B
HURN Huron Consulting Group Inc

N/A

USD 2.16B
CRAI CRA International Inc

N/A

USD 1.31B
FORR Forrester Research Inc

N/A

USD 0.31B
RGP Resources Connection Inc

N/A

USD 0.29B
AERT Aeries Technology Inc.

N/A

USD 0.03B
VCIG VCI Global Limited Ordinary Sh..

N/A

USD 0.02B
GRNQ GreenPro Capital Corp

N/A

USD 7.73M
AERTW Aeries Technology Inc.

N/A

N/A

ETFs Containing SBCWW

N/A

Market Performance

  Market Performance vs. Industry/Classification (Consulting Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector